FDA: Higher doses of Xeljanz increase blood clot, death risk in UC - Healio

FDA: Higher doses of Xeljanz increase blood clot, death risk in UC  Healio

The FDA on Friday issued a safety alert and approved new warnings for the 10-mg, twice-daily dosage of tofacitinib after a possible increased risk for pulmonary ...